For years, surgeons have treated the neck primarily as a structural corridor or a gateway for life-saving cancer interventions, unaware that this narrow passage also functions as the brain's essential metabolic exhaust pipe. A groundbreaking study from Weill Cornell Medicine has revealed that
The discovery of a germline mutation in a prostate cancer patient facilitates cascade testing for family members who may be at risk for breast, pancreatic, or ovarian cancers. This clinical reality highlights the expanding role of genetic identification as a cornerstone of modern oncology, moving
The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical
A multi-layered screening strategy combining mammography and ultrasound offers the highest probability of catching treatable cancers at their most localized and manageable stage. As the landscape of preventive medicine continues to evolve in 2026, healthcare professionals are increasingly
The core architecture of a chimeric antigen receptor relies on a single-chain variable fragment linked to intracellular signaling components that ignite T cell proliferation. As the pharmaceutical industry entered the second half of the current decade, the shift from experimental novelty to
Polydopamine nanotubes provide a versatile clinical tool that can disrupt cancer cell activity through both photothermal heating and localized electrical stimulation. For years, the challenge of delivering targeted therapy without damaging surrounding healthy tissue has remained a central hurdle in